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Abstract
Folate is generally considered as a safe water-soluble vitamin for supplementation. However, we do not have enough information to confirm
the potential effects and safety of folate supplementation and the interaction with vitamin B12 deficiency. It has been hypothesized that a greater
methyl group supply could lead to compensation for vitamin B12 deficiency. On this basis, the present study was conducted to examine the effects 
of high-dose folic acid (FA) supplementation on biomarkers involved in the methionine cycle in vitamin B12-deficient rats. Sprague-Dawley rats
were fed diets containing either 0 or 100 μg (daily dietary requirement) vitamin B12/kg diet with either 2 mg (daily dietary requirement) or 100
mg FA/kg diet for six weeks. Vitamin B12-deficiency resulted in increased plasma homocysteine (p<0.01), which was normalized by dietary supplementation
of high-dose FA (p<0.01). However, FA supplementation and vitamin B12 deficiency did not alter hepatic and brain S-adenosylmethionine (SAM)
and S-adenosylhomocysteine (SAH) concentrations and hepatic DNA methylation. These results indicated that supplementation of high-dose FA improved
homocysteinemia in vitamin B12-deficiency but did not change SAM and SAH, the main biomarkers of methylating reaction. 
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Vitamin B12 functions as a coenzyme in two reactions: the 
synthesis of methionine from homocysteine in the reaction 
catalysed by 5-methyltetrahydrofolate-dependent methionine 
synthase and the isomerization of L-methylmalonyl-CoA to 
succinyl-CoA in the reaction catalysed by L-methylmalonyl-CoA 
mutase (Ludwig & Matthews, 1997). Vitamin B12-deficiency has 
been shown to cause depletion of intracellular folate concentration 
in rat liver (Kutzbach et al., 1967) and human erythrocytes 
(Cooper & Lowenstein, 1964). Impaired activity of L-methy-
lmalonyl- CoA mutase leads to a high-level of methylmalonic 
acid (MMA) in serum and urine, which is a useful biomarker 
of vitamin B12 deficiency (Baik & Russell, 1999; Stabler, 2001). 
Deficiencies of vitamin B12 and folate have been associated with 
brain-related disorders, including reversible dementia (Goodwin 
et al., 1983). 
During vitamin B12-deficiency, decreased activity of methionine 
synthase may cause trapping of folate as 5-methylfolate. 
Therefore, the methyl group is not available to methylate 
homocysteine, which leads to high levels of plasma homocysteine 
and the decreased synthesis of methionine, S-adenosylmethione 
(SAM), and other metabolites of the methylation cycle (Baik & 
Russell, 1999; Stabler, 2001). Vitamin B12 deficiency is associated 
with megaloblastic anemia, neuropathy, and neuropsychiatric 
disorder (Baik & Russel, 1999). These symptoms may be linked 
to the block in homocysteine remethylation or the resulting 
homocysteinemia. 
Although folate is a water-soluble vitamin with a low potential 
toxicity for supplementation and fortification (Bailey & Berry, 
2005), there is a potential risk that it may mask undiagnosed 
vitamin B12-deficiency in pernicious anemia because folic acid 
(FA) supplementation may improve hematological indices but not 
the neurological disease (Lachance, 1998). The current animal 
studies reported negative or benefic effects of excess FA 
supplementation. FA supplementation may promote the 
development and progression of already existing, undiagnosed 
preneoplastic and neoplastic lesions (Kim, 1999). In rats, excess 
FA supplement (40 mg/kg diet) accelerated the development of 
colonic neoplasia in rodent model of cancer (Sohn et al., 2003). 
However, Kim et al. (1996) has reported that moderate-dose 
folate supplementation (8 mg folate/kg diet) leads to a reduction 
in the evolution of macroscopic colonic neoplasia, but high-dose 
FA supplementation (40 mg folic acid/kg diet) did not show the 
benefic effects. On the contrary, FA supplementation (5 mg folic 
acid/kg body weight per day) interferes with gastric carcinogenesis 
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induced by N-methyl-N’-nitrosoguanidine in rats, and the authors 
suggested that the higher serum FA concentration of rats may 
play an important role in the prevention of gastric cancer (Fei 
et al., 2006). It is also hypothesized that a greater methyl group 
supply by FA supplementation could lead to compensation for 
vitamin B12-deficiency. The objective of this study was to 
investigate the effects of high-dose FA supplementation on 




Lactobacillus casei (7469) was obtained from American Type 
Culture Collection (Manassas, VA, USA). Folic acid depleted 
casein medium was obtained from Difco Laboratories (Detroit, 
MI, USA) and 7-fluoro-benzo-2-oxa-1, 3-diazole-4-sulfonate 
(SBDF) was obtained from Wako Chemicals (Osaka, Japan), 
respectively. L-Homocystine, tri-n-butylphosphine, DL-methionine, 
folic acid, SAM and SAH were purchased from Sigma 
(Sigma-Aldrich Chemical Co., St. Louis, MO, USA). CpG 
methylase was obtained from Perkin-Elmer (Waltham, MA, 
USA) and [
3H-methyl]S-adenosylmethionine was purchased from 
Amersham Life Science (Picataway, NJ, USA). All chemicals 
were of the highest purity commercially available. 
Animals and diets 
Animal experiments followed protocols approved by the NIH 
Guide for the Care and Use of Laboratory Animals (NIH 
Publications NO. 80-23, revised 1996). Male Sprague-Dawley 
rats (initial weight of 170-180 g) were obtained from SLC 
(Tokyo, Japan) and housed individually in wire-mesh cages with 
a daily light cycle from 0600 to 2000 hr and controlled 
temperature (20 ± 2℃) and humidity (50 ± 5%). After a 1-wk 
acclimation period, the rats were classified into four groups (n=8) 
by a randomised block design. They were fed semisynthetic 
powdered diets consisting of the following (g/kg): carbohydrate, 
482 (corn starch, 340, dextrinzed cornstarch, 42, sucrose, 100); 
protein, 200 (casein, >85%); lipids, 50 (soybean oil); cellulose, 
35; pectin, 50; and minerals plus vitamins (AIN93). We added 
5% of pectin to the diets to accelerate vitamin B12-depletion 
(Cullen & Oace, 1989). Groups of rats were fed one of the 
following diets: 1) control diet (100 μg vitamin B12 and 2 mg 
FA/kg diet); 2) FA supplemented diet (100 μg vitamin B12 and 
100 mg FA/kg diet) (we added 100 mg FA to the basal diet 
for providing 5 mg FA/kg body weight/day.) ; 3) vitamin 
B12-deficient diet (0 μg vitamin B12 and 2 mg FA/kg diet); 4) 
vitamin B12-deficient/ FA supplemented diet (0 μg vitamin B12 
and 100 mg FA/kg diet). During the experiment, body weight 
was measured once a week and food intake was determined 3 
times each week.
Sample collection 
Twenty-four hr urine samples for methylmalonic acid (MMA) 
measurement were collected in tubes containing 5 ml of 0.4 N 
sulphuric acid on the 42
nd day and stored at -20℃ until assay. 
Following 6 wks of feeding experimental diets, rats were 
anesthetized and blood was collected by heart puncture using 
a heparinized syringe. Blood was immediately centrifuged for 
15 min at 3,000 rpm to collect plasma. Livers and brains were 
removed, weighed and rapidly frozen. Samples were stored at 
-70℃ until use.
Plasma homocysteine
Analysis of plasma homocysteine was performed using a 
modification of the liquid chromatographic method described by 
Araki and Sako (1987). Separation and quantification was carried 
out with a Shimadzu system with a LC-10AT pump, an 
RF-10AXL fluorescence detector, and a Chromatopac D-R6A 
integrator (Shimadzu, Kyoto, Japan). Homocysteine was 
separated with a Hypersil ODS analytical column (250×4.6 mm 
I.D., 5 μm particle size (Thermo-Keystone, Runcorn, Great 
Britain). LC was run isocratically with a 20 mM sodium acetate 
buffer, pH 4.0, containing 2% methanol, at a flow rate of 1 
mL/min. Filtered samples (50 μl) were injected and the 
fluorescence intensity was measured with excitation at 385 nm 
and emission at 515 nm. 
Plasma and liver folate
Folate was analysed by a microplate assay method using L. 
casei (ATCC 7469) according to Tamura (1990). Portions of liver 
were homogenized and autolysed for hydrolysis of γ-glutamyl 
residues in the presence of sodium ascorbate at 37℃, and the 
supernatants were used for folate assay. 
Liver and brain S-adenosylmethionine and S-adenosylhomocysteine
Portions of frozen liver were homogenized with 0.4 M HClO4. 
Samples were centrifuged at 2000×g at 4℃ for 30 min. Each 
supernatant was filtered through a 0.45-μm filter. SAM and SAH 
were measured on a Shimadzu LC-10 HPLC equipped with 
250×4.6 mm Ultrasphere 5-μm ODS Betasil analytical column 
(Thermo-Keystone, Runcorn, Great Britain) according to Wagner 
et al. (1984)
Genomic DNA methylation 
To assess the methylation status of CpG sites in genomic DNA, 
the in vitro methyl acceptance capacity of DNA was determined 
using [
3H-methyl]SAM as a methyl donor and CpG DNA 124 Vitamin B12-deficiency and dietary folic acid-supplementation













100 2 20.5 ± 0.4
1) 358.3 ± 6.0 7.31 ± 0.13  0.358 ± 0.005
a3) 0.0351 ± 0.0007
 
100 100 21.4 ± 0.5 361.6 ± 8.0 7.41 ± 0.20 0.346 ± 0.004
ab 0.0353 ± 0.0009
0 2 21.7 ± 0.6 365.0 ± 7.3 7.50 ± 0.18 0.347 ± 0.003
ab 0.0372 ± 0.0012
0 100 21.6 ± 0.8 359.3 ± 13.2 7.35 ± 0.31 0.341 ± 0.004
b 0.0341 ± 0.0006
Significant effects as determined by two-way ANOVA
Vitamin B12-deficiency  NS
4) NS 0.043 NS
FA supplement NS NS NS NS
Vitamin B12-deficiency x FA supplement NS NS NS NS
1) Values  are  mean ± SE  (n=8). 
2) Feed  Efficiency  Ratio,  g  gain/g  feed
3) Values  in  a  column  with  different  letters  differ  at  p<0.05  by  two-way ANOVA  and  Duncan's  multiple-range  test. 
4) NS,  not  significantly  different  among  four  groups  (p>0.05)
Table 2. Effect of high-dose FA supplementation on urinary methylmalonic acid,











100 2   29 ± 18
1)b2) 252.8 ± 38.1
b 23.1 ± 3.4
b
100 100   37 ± 26
b 660.0 ± 112.4
a 31.1 ± 5.4
a
0 2 3976 ± 590
a 334.5 ± 92.2
b 14.2 ± 2.9
c
0 100 3570 ± 523
a 337.3 ± 179.2
b 21.5 ± 2.2
b
Significant effects as determined by two-way ANOVA
Vitamin B12-deficiency 0.000 0.002 0.004
FA supplement NS
3) 0.000 0.000
Vitamin B12-deficiency x 
FA supplement
NS 0.000 0.032
1) Values  are  mean ± SE  (n=8). 
2) Values in a column with different letters differ at p<0.05 by two-way ANOVA and 
Duncan's  multiple-range  test. 
3) NS,  not  significantly  different  among  four  groups  (p>0.05)
methylase according to Pogribny et al. (1999) Briefly, DNA (1 
μg) purified from liver was incubated with 185 kBq of 
[
3H-methyl]SAM, 4 units of Sss1 methyltransferase, 1 X Sss1 
buffer (50 mmol/L NaCl, 10 mmol/L Tris-HCl, 10 mmol/L 
EDTA and 1 mmol/L dithiothreitol, pH 8.0). Samples were 
subsequently applied on DE-81 filters, washed, dried and counted 
using scintillation counter. The endogenous DNA methylation 




Methylmalonic acid was determined using the spectroscopic 
method by coupling with diazotized p-nitroaniline (Giorgio & 
Plaut, 1965). 
Statistical analysis
Results were expressed as mean ± SE. Data were analyzed with 
a two-way ANOVA (dietary vitamin B12 and dietary folate) using 
SPSS 14.0 for window (SPSS, Inc., Chicago, IL, USA). When 
the ANOVA was significant, multiple comparisons between 
means were made using Duncan’s multiple range test. 
Differences were considered significant at p<0.05.
Results
In the present study, all the rats appeared to be healthy and 
FA-supplemented diets and vitamin B12-deficient diets did not 
alter food intake and body weight of the rats from control during 
the experimental periods (Table 1). However, rats fed vitamin 
B12-deficent/ FA-supplemented diets had slightly lower food 
efficiency ratio (g gain/g feed) compared to other experimental 
groups (p<0.05). Rats fed the vitamin B12-deficient diets excreted 
high levels of methylmalonic acid in urine (3976 ± 590 or 3570
± 523  μmol/kg/d) (p<0.001), which indicates vitamin B12- 
deficiency induced (Table 2). 
FA supplementation increased liver folate concentration 
significantly both in the rats fed vitamin B12-adequate diets (31.1
± 5.4 vs. 23.1 ± 3.4 nmol/g) and in the rats fed vitamin B12- 
deficient diets (21.5 ± 2.2
  vs. 14.2 ± 2.9
  nmol/g) (p<0.01) (Table 
2). However, FA supplementation increased plasma folate only 
in the rats fed vitamin B12-adequate diets (660.0 ± 112.4 vs. 252.8
±3 8 . 1
  pmol/ml), but not in the rats fed vitamin B12-deficient 
diets (337.3 ± 179.2
  vs. 334.5 ± 92.2
  pmol/ml) (p<0.01). 
Vitamin B12-deficient/folate-adequate diet increased plasma 
homocysteine compared to control group (7.65 ± 1.65 vs. 4.66
± 0.62 nmol/ml) (p<0.01) (Fig. 1). FA supplementation 
normalized plasma homocysteine level from 7.65 ± 1.65 nmol/ml 
to 5.68 ± 1.43 nmol/ml (p<0.01).
Regarding the main biomarkers involved in the functioning of 
the methionine cycle, liver and brain SAM and SAH levels were 
not altered by vitamin B12-deficient diets or FA-supplemented 
diets (Table 3). In consequence, the SAM:SAH ratio remained 
unchanged by vitamin B12-deficiency and FA supplementation. 
Hepatic DNA methylation also was not altered by vitamin 





Fig. 1. Effect of high-dose FA supplementation on plasma homocysteine in rats 
fed vitamin B12-adequate or vitamin B12-deficienct diets in a 2×2 design. Values 
are expressed as means with their standard errors depicted by vertical bars (n=8). 
Two-way  ANOVA;  FA  supplementation,  p<0.01;  vitamin  B12,  p<0.01.  Different 
superscripts  are  significantly  different  at  p<0.05  by  Duncan's  multiple-range  test. 
























100 2 10.5 ± 1.7
1) 3.0 ± 0.9 31.4 ± 8.2 14.7 ± 0.9 1.97 ± 0.15 7.5 ± 0.6 2899 ± 250
100 100 10.7 ± 1.7 3.1 ± 1.2 28.5 ± 5.9 15.7 ± 3.0 1.77 ± 0.18 8.6 ± 1.5 2921 ± 324
0 2 11.4 ± 2.0 3.4 ± 1.3 37.4 ± 7.5 14.7 ± 1.3 1.82 ± 0.20 7.8 ± 1.2 2727 ± 348
0 100 10.8 ± 1.6 3.2 ± 0.7 31.6 ± 3.2 15.1 ± 1.7 1.86 ± 0.22 8.3 ± 0.9 2879 ± 253
Significant effects as determined by two-way ANOVA
Vitamin B12-deficiency NS
2) NS NS NS NS NS NS
FA supplement NS NS NS NS NS NS NS
Vitamin B12-deficiency x 
FA supplement NS NS NS NS NS NS NS
1) Values  are  mean ± SE  (n=8). 
2) NS,  not  significantly  different  among  four  groups  (p>0.05)
Discussion
The present results showed that dietary supplementation of 
high-dose FA in vitamin B12-adequate and vitamin B12-deficienct 
rats did not affect body weight gain. It has been reported that 
pectin accelerates vitamin B12-deficiency by interfering with 
enterohepatic recycling of vitamin B12 and by stimulating 
microbial propionate production (Cullen & Oace, 1989). In this 
study, five percent of pectin was added to the basal diets to 
accelerate vitamin B12 depletion. Excretion of high levels of 
MMA in urine indicated that vitamin B12-deficiency was induced 
by feeding vitamin B12-deficient diet (p<0.001) (Table 2). 
Association between low vitamin B12 status and elevated urinary 
MMA excretion is well established (Stabler, 2001). 
As expected, FA supplementation increased plasma folate and 
hepatic folate 2.6 folds and 1.3 folds in rats fed vitamin 
B12-adequate diets, respectively (p<0.001). Vitamin B12-deficieny 
decreased hepatic folate, but did not alter plasma folate (Table 
2). Plasma folate was increased by FA supplementation only in 
the rats fed vitamin B12-adequate diets, not in the rats fed vitamin 
B12-deficient diet (p<0.01). These results suggest that vitamin 
B12 deficiency may cause ‘methylfolate trapping’, which leads 
to the impaired storage of intracellular folate in spite of relatively 
high plasma folate levels (Stabler, 2001). 
Because vitamin B12 functions as a coenzyme for remethylation 
of homocysteine, vitamin B12 deficiency increased plasma 
homocysteine, implying less homocysteine being remethylated 
to methionine (Fig. 1). The present study demonstrated that 
dietary FA supplementation lowered plasma homocysteine to the 
control level in vitamin B12-deficient rats (Fig. 1). Plasma 
homocysteine is known as a biomarker for both vitamin B12 and 
folate status and plasma homocysteine is inversely related with 
folate status (Ubbink et al., 1993). Mildly elevated serum 
homocysteine levels have been considered to be an important 
risk factor for cognitive and neurological diseases, such as 
Alzheimer disease and Parkinson disease and brain ischemia 
(Boutell et al., 1998; Kuhn et al, 1998; Seshadri et al., 2002; 
White  et al., 2001). 
SAM is an essential component in many methylation reactions 
(Finkelstein, 1990). Both folate and vitamin B12 are involved in 
remethylation of homocysteine to methionine, which is a 
precursor of SAM, the primary methyl group donor for DNA, 
proteins, phospholipids, amines and neurotransmitters (Finkelstein, 
1990; Selhub & Miller, 1992). SAM is converted to SAH after 
transfer of the methyl group. DNA methylation is an important 126 Vitamin B12-deficiency and dietary folic acid-supplementation
epigenetic determinant in gene expression, the maintenance of 
DNA integrity and stability, chromatin modifications and the 
development of mutations (Jones & Baylin, 2002; Jones & Laird, 
1999). In the rodent model, a definite effect of FA 
supplementation on SAM and SAH concentrations has not been 
established yet. In the present study, FA supplementation did 
not affect hepatic and brain SAM and SAH concentrations and 
SAM:SAH ratio, although FA supplementation increased hepatic 
folate concentration. Hepatic genomic DNA methylation was not 
significantly changed by vitamin B12-deficiency and FA 
supplementation. Therefore, the present results may indicate that 
high-dose FA supplementation in vitamin B12  deficiency may not 
affect the efficiency of methylation in the liver and brain, which 
implies “methylfolate trapping”. Achón et al. (1999) showed that 
supranormal folate intakes may be associated with impairment 
in dietary protein metabolic utilization and this effect could be 
related with a xenobiotic behavior of FA at high levels. In accord 
with the present findings, a current study also reported that excess 
dietary FA (40 mg folate/kg diet) did not alter hepatic SAM 
and SAH in aged rats (Achón et al., 2007). We are speculating 
the reason why vitamin B12-deficiency did not alter most 
biomarkers of methylating reaction, plausibly due to the short 
experimental period of vitamin B12  depletion in this study. 
In summary, dietary supplementation of high-dose FA 
improved homocysteinemia in vitamin B12-deficient rats but did 
not alter hepatic and brain SAM and SAH levels which are the 
main biomarkers of methylating reaction in rats, although FA 
supplementation increased hepatic folate concentration. 
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